CLOS
GILD icon

Compagnie Lombard Odier SCmA’s Gilead Sciences GILD Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-12,500
Closed -$56K – 524
2019
Q4 		$56K Hold
12,500
– – ﹤0.01% 350
2019
Q3 		$59K Hold
12,500
– – ﹤0.01% 350
2019
Q2 		$87K Hold
12,500
– – ﹤0.01% 321
2019
Q1 		$80K Buy
+12,500
New +$831K ﹤0.01% 366

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Compagnie Lombard Odier SCmA's GILD Position: Q1 2025 in Review

Compagnie Lombard Odier SCmA sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 560 shares — an estimated $51.7K sold.

Compagnie Lombard Odier SCmA first reported a position in GILD in Q4 2013 and held it in 45 quarters. The position peaked at $184M in Q3 2014. 2,014 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

  • Compagnie Lombard Odier SCmA reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 560 Gilead Sciences shares in Q1 2025, an estimated $51.7K.
  • Compagnie Lombard Odier SCmA first reported a position in Gilead Sciences in Q4 2013 and held it in 45 quarters.
  • Compagnie Lombard Odier SCmA's Gilead Sciences position peaked at $184M in Q3 2014.
  • 2,014 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2025, filed 16 Apr 2025.